顺气通腑汤灌肠在癌痛患者药源性便秘致阴液亏虚中的应用效果

摘要
图/表
参考文献(22)
相关文章 (15)

全文: PDF (667 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨顺气通腑汤灌汤治疗癌痛患者药源性便秘致阴液亏虚的临床应用价值。方法选择2019年1月至12月赣州市肿瘤医院确诊的阴液亏虚便秘癌痛80 例患者，采用随机数字表法分为试验组与对照组，每组各40例。对照组采用口服乳果糖治疗，试验组采用口服乳果糖治疗基础上联合顺气通腑汤灌肠治疗。观察两组治疗2个疗程后的近期疗效、满意度，观察两组的治疗前后便秘症状严重度量表（Wexner）及生活质量量表（PAC-QOL）评分，记录不良反应总发生率。结果试验组治疗2 个疗程后的Wexner 评分低于对照组，试验组治疗2 个疗程后的PAC-QOL 各维度评分及总分低于对照组，差异均有统计学意义（P＜0.05）。试验组的临床总有效率高于对照组，差异有统计学意义（P＜0.05）。两组治疗过程未出现不良反应。试验组的总满意度高于对照组，差异有统计学意义（P＜0.05）。结论药源性便秘致阴液亏虚的癌痛患者经顺气通腑汤灌肠治疗的疗效较好，可改善其生活质量，提高治疗满意度，确保癌痛治疗的顺利进行。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：顺气通腑汤, 灌肠, 癌痛, 药源性便秘, 阴液亏虚

Abstract：Objective To explore the clinical application value of Shunqi Tongfu Decoction enema in the treatment of Yin deficiency caused by drug-induced constipation in patients with cancer pain. Methods A total of 80 patients with Yin deficiency，constipation and cancer pain were diagnosed in Ganzhou Cancer Hospital from January to December 2019 were selected. They were divided into the control group and the experimental group according to random number table method，40 cases in each group. The control group was treated with oral Lactulose，and the experimental group was treated with oral Lactulose combined with Shunqi Tongfu Decoction enema. The short-term efficacy and satisfaction of the two groups at 2 courses after treatment were observed. The scores of constipation symptom severity scale(Wexner) and quality of life scale (PAC-QOL) in the two groups were observed before and after treatment，and the total incidence rate of adverse reactions was recorded. Results The score of Wexner scale in the experimental group at 2 courses after treatment was lower than that in the control group，the scores of each dimension of PAC-QOL in the experimental group at 2 courses after treatment were lower than those in the control group，and the differences were statistically significant (P＜0.05). The clinical total effective rate of the experimental group was higher than that of the control group，and the difference was statistically significant (P＜0.05). There were no adverse reactions in the two groups.The total satisfaction of the experimental group was better than that of the control group，the difference was statistically significant (P＜0.05). Conclusion The Yin deficiency caused by drug-induced constipation in patients with cancer pain were treated by Shunqi Tongfu Decoction enema，and the curative effect was good，which could improve their quality of life，improve treatment satisfaction，and ensure the smooth progress of cancer pain treatment.

Key words： Shunqi Tongfu Decoction Enema Cancer pain Drug-induced constipation Yin deficiency

收稿日期: 2021-05-28

基金资助:江西省卫生计生委科技计划项目（20197402）

作者简介: 黄小梅，女，副主任护师，护理部主任，研究方向：癌痛护理

引用本文:

黄小梅；朱志方；张玲珍；刘静；易琰斐；刘勇. 顺气通腑汤灌肠在癌痛患者药源性便秘致阴液亏虚中的应用效果[J]. 中国当代医药, 2022, 29(1): 181-184.
HUANG Xiaomei1 ZHU Zhifang2 ZHANG Lingzhen1 LIU Jing2 YI Yanfei2 LIU Yong2. Effect of Shunqi Tongfu Decoction enema in the treatment of Yin deficiency caused by drug-induced constipation in patients with cancer pain. 中国当代医药, 2022, 29(1): 181-184.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2022/V29/I1/181

[1]	卢帆，宋莉，刘慧.癌性神经病理性疼痛的评估和诊疗现状[J].中国疼痛医学杂志，2015，21（9）：692-696.
[2]	ALMouaalamy N.Opioid-Induced Constipation in Advanced Cancer Patients[J].Cureus，2021，13（4）：e14386.
[3]	Kanbayashi Y，Amaya F，Ueno H，et al.Factors affecting the effect of naldemedine for opioid-induced constipation：a single-institution，retrospective analysis[J].Pharmazie，2021，76（4）：175-178.
[4]	王珺文，孙会会，姜元喜，等.功能性便秘和便秘型肠易激综合征的治疗研究进展[J].国际消化病杂志，2021，41（1）：19-22.
[5]	佟琦媛，王新.便通胶囊对比芪蓉润肠口服液治疗抗精神病药物所致药源性便秘的临床疗效研究[J].世界中医药，2018，13（2）：363-365，369.
[6]	李剑英，方子欣，宋琳，等.加味增液承气汤治疗阿片类镇痛药物所致肠燥津亏型便秘的临床疗效[J].湖南中医药大学学报，2013，33（9）：76-78.
[7]	刘会英，田野，宋震，等.中医药对抗精神病药物所致的药源性便秘治疗的研究进展[J].国际医药卫生导报，2019，25（19）：3205-3206.
[8]	孙晓红.功能性消化不良的罗马Ⅳ标准解读[J].中华全科医师志，2017，16（9）：661-663.
[9]	国家中医药管理局.中医病证诊断疗效标准[M].南京：南京大学出版社，1994：11.
[10]	周仲瑛.中医内科学[M].北京：中国中医药出版社，2007：249-256.
[11]	孙兵，车晓明.视觉模拟评分法（VAS）[J].中华神经外科杂志，2012，28（6）：645.
[12]	Stedman MR，Watford DJ，Chertow GM，et al.Karnofsky Performance Score-Failure to Thrive as a Frailty Proxy?[J].Transplant Direct，2021，7（7）：e708.
[13]	郭锦.隧道式拖线术对高位后马蹄型肛周脓肿的疗效及Wexner 量表积分的影响[J].社区医学杂志，2018，16（2）：33-34.
[14]	宋玉磊，林征，林琳，等.中文版便秘患者症状自评量表的信度与效度研究[J].护理学杂志，2012，27（7）：73-76.
[15]	Ghoshal A.Fentanyl，Morphine，and Opioid-Induced Constipation in Patients with Cancer-Related Pain[J].Indian J Palliat Care，2020，26（4）：535-536.
[16]	Saha S，Nathani P，Gupta A.Preventing Opioid -Induced Constipation-Reply[J].JAMA Intern Med，2021，181（5）：726-727.
[17]	ZhangYY，ZhouR，GuWJ.EfficacyandSafetyofMethylnaltrexone for the Treatment of Opioid-Induced Constipation：A Metaanalysis of Randomized Controlled Trials[J].Pain Ther，2021，10（1）：165-179.
[18]	程洪权，崔雅飞.浅谈《伤寒论》中“便秘病”的治疗方法[J].中国肛肠病杂志，2016，36（5）：70-71.
[19]	陶智会，仝欣，徐蔚杰，等.白术和胃方治疗阿片相关性便秘的疗效观察及对IL-6、TRPV1 的影响[J].中国中医药科技，2021，28（2）：187-191.
[20]	周稼荣，刘毅，陈金鹏，等.基于网络药理学的夏黄颗粒治疗阿片类药物所致便秘的作用机制研究[J].中草药，2020，51（23）：6015-6022.
[21]	吴施国，赵芮，赵金龙，等.癌症疼痛的中医外治法研究概况[J].现代中医药，2020，40（1）：113-116.
[22]	张景岳.景岳全书[M].北京：人民卫生出版社，2010：763.